Telix Pharmaceuticals axes $25 million share purchase plan
MELBOURNE: Billion-dollar cancer imaging biotech Telix Pharmaceuticals has cancelled the $25 million share ... read more
Virtus Health shares jump to five-year high as CapVest raises bid
LONDON: UK-based CapVest Partners has lifted its non-binding offer for Virtus Health just ... read more
RAT demand leads to Sigma Healthcare earnings upgrade
MELBOURNE: Pharmaceuticals wholesaler Sigma Healthcare has started the session more than 4 per ... read more
Green whistle maker soars as FDA removes clinical hold
SYDNEY: Medical Developments International, which makes the ‘green whistle’ painkiller known as Penthrox, ... read more
